These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Blind corticosteroid injection as primary treatment of trigger finger]. Author: Kongensgaard TB, Schroll L, Hansen RL. Journal: Ugeskr Laeger; 2018 Dec 10; 180(50):. PubMed ID: 30547874. Abstract: Trigger finger (TF) is a common condition with a lifetime prevalence up to 2%. Local corticosteroid injection at the level of the A1 pulley is a frequently used and safe treatment for TF with cure rates around 50% in randomised controlled trials, while surgical release has cure rates near 100% but more severe complications. Blind local corticosteroid injection has the same effect as ultrasound-guided local corticosteroid injection on cure rates, and the effect remains the same, whether the steroid is placed intra-sheath or extra-sheath. The treatment of TF can be carried out as blind local corticosteroid injection in general practice before possible referral to an orthopaedic specialist.[Abstract] [Full Text] [Related] [New Search]